Biomedicine & Pharmacotherapy · 2024 · 25 citations · 94 references
MedicinePharmacokineticsPharmacologyNeurochemistryNeuropharmacologyPsychopharmacologyAntidepressant PharmacologyAnxiolytic PharmacologyDrug DispositionNeurochemical PharmacologyPharmacokinetics In DementiaSerotonergic PharmacologyAnxiolytic SafetyCa2+ SignalingKratom AlkaloidsOpioid Withdrawal ManagementPharmacodynamics Of Neuroactive DrugsPlant AlkaloidsSerotonergic NeurotransmissionWithdrawal Symptoms
Mitragynine is one of the main psychoactive alkaloids in Mitragyna speciosa Korth. (kratom). It has opium-like effects by acting on μ-, δ-, and κ-opioid receptors in the brain. The compound also interacts with other receptors, such as adrenergic and serotonergic receptors and neuronal Ca2+ channels in the central nervous system to have its neuropharmacological effects. Mitragynine has the potential to treat diseases related to neurodegeneration such as Alzheimer’s disease and Parkinson’s disease, as its modulation on the opioid receptors has been reported extensively. This review aimed to provide an up-to-date and critical overview on the neuropharmacological effects, mechanisms of action, pharmacokinetics and safety of mitragynine as a prospective psychotropic agent. Its multiple neuropharmacological effects on the brain include antinociceptive, anti-inflammatory, antidepressant, sedative, stimulant, cognitive, and anxiolytic activities. The potential of mitragynine to manage opioid withdrawal symptoms related to opioid dependence, its pharmacokinetics and toxic effects were also discussed. The interaction of mitragynine with various receptors in the brain produce diverse neuropharmacological effects, which have beneficial properties in neurological disorders. However, further studies need to be carried out on mitragynine to uncover its complex mechanisms of action, pharmacokinetics, pharmacodynamic profiles, addictive potential, and safe dosage to prevent harmful side effects.
94
Andrew C. Kruegel, Madalee M. Gassaway, Abhijeet Kapoor et al. · Journal of the American Chemical Society · 2016 · 320 citations · Full text
András Váradi, Gina F. Marrone, Travis C. Palmer et al. · Journal of Medicinal Chemistry · 2016 · 320 citations · Full text
Morphine‐induced respiratory depression is independent of β‐arrestin2 signalling
Andrea Kliewer, Alexander Gillis, R. W. Hill et al. · British Journal of Pharmacology · 2020 · 248 citations · Full text
Medicine, Neurobiology, Pharmacology +15